Top Startup and Tech Funding News – September 16, 2025

Figure Raises Over $1B in Series C Funding for Humanoid Robotics

Figure, a San Jose–based AI robotics startup, announced it has closed a Series C round of over $1 billion, bringing its post-money valuation to $39 billion. Parkway Venture Capital led the round, with participation from industry giants including Nvidia, Intel Capital, LG Technology Ventures, Salesforce, T-Mobile Ventures, and Qualcomm Ventures.

Figure says it will use the new funding to scale its humanoid robot platform (Helix and BotQ) into homes and commercial operations, expand its AI training and simulation infrastructure, and double down on data collection to improve performance. The infusion comes amid a surge in VC interest in humanoid robots and AI-driven automation, as companies race to address labor shortages in logistics, manufacturing, and home services.

Funding Details:

• Startup: Figure

• Investors: Parkway Venture Capital (lead), Nvidia, Intel Capital, LG Technology Ventures, Salesforce, T-Mobile Ventures, Qualcomm Ventures, Brookfield Asset Management, Macquarie Capital, Align Ventures, Tamarack Global.

• Amount Raised: Over $1 billion

• Total Raised: Not disclosed (prior round was $675M)

• Funding Stage: Series C

• Funding Date: September 16, 2025

Nothing Raises $200M in Series C Funding for Next-Gen Electronics

London-based Nothing, the consumer electronics startup founded by Carl Pei, raised $200 million in a Series C round, valuing the company at about $1.3 billion. The round was led by Tiger Global, with participation from existing backers including GV, Highland Europe, EQT, Latitude, I2BF, and Tapestry also participated, along with new strategic investors such as Zerodha co-founder Nikhil Kamath and Qualcomm Ventures.

Nothing plans to use the capital to accelerate its expansion beyond smartphones into a broader lineup of AI-driven devices (phones, watches, audio, and potentially smart glasses, robots, and electric vehicles). The fresh funding comes as Nothing surpasses $1 billion in cumulative sales and prepares to scale its distinctive transparent hardware design to new markets.

Funding Details:

• Startup: Nothing

• Investors: Tiger Global (lead), GV, Highland Europe, EQT, Latitude, I2BF, Tapestry, Nikhil Kamath (Zerodha), Qualcomm Ventures.

• Amount Raised: $200 million

• Total Raised: Over $450 million to date

• Funding Stage: Series C

• Funding Date: September 16, 2025

PharmEasy Secures $205 million in Debt Financing

Indian healthtech unicorn PharmEasy has raised INR 1,700 crore ($205 million) in fresh debt financing, led by 360 ONE, with participation from Alkram Ventures, MVS Ventures, Bennett Coleman, and others. The funding will be used primarily to repay a loan from Goldman Sachs, as PharmEasy works to restructure its obligations following a valuation cut of roughly 90%.

The debt round comes amid broader efforts by the online pharmacy to stabilize its finances and focus on core operations. PharmEasy’s founders have indicated that additional fundraising or restructuring may follow to support the business’s turnaround.

Funding Details:

• Startup: PharmEasy

• Investors: 360 ONE (lead), Alkram Ventures, MVS Ventures, Bennett Coleman, others.

• Amount Raised: INR 1,700 crore (approximately $210 million)

• Total Raised: Not disclosed

• Funding Stage: Debt Financing

• Funding Date: September 16, 2025

MarqVision Raises $48M Series B Funding for AI Brand Protection

MarqVision, a Los Angeles–based AI startup specializing in detecting and removing online counterfeits and digital piracy, has closed $48 million Series B funding to protect brands with AI. The round was led by Peak XV Partners (recently spun out from Sequoia) and included strategic investors Salesforce Ventures, Coral Capital, HSG (ex-Sequoia China), and YC partner emeritus Michael Seibel.

MarqVision says it will use the funding to drive global expansion of its managed-service platform, invest in product innovation, and strengthen its AI-powered brand protection offerings for e-commerce and social media platforms. The funding marks one of Peak XV’s first major U.S. investments since its rebrand and underscores demand from major brands to safeguard intellectual property online.

Funding Details:

• Startup: MarqVision

• Investors: Peak XV Partners (lead), Salesforce Ventures, Coral Capital, HSG, Michael Seibel, Y Combinator (via Seibel), others.

• Amount Raised: $48 million

• Total Raised: Not disclosed

• Funding Stage: Series B

• Funding Date: September 16, 2025

Nofence Closes $35M in Series B Funding to Scale Virtual Fencing Tech

Nofence, a Norway-based agtech startup that provides virtual-fencing solutions for livestock, has closed a Series B round of over $35 million to scale virtual fencing technology. The round was led by the European Circular Bioeconomy Fund, with participation from Capagro, Nysnø Climate Investments, Climate Innovation Capital, and Speedinvest; existing backers Sandwater, Momentum, and Ferd also increased their stakes.

The funding – one of Europe’s largest agtech rounds this year – will enable Nofence to accelerate expansion in the U.S. and other markets, further develop its solar-powered GPS collar technology, and scale up customer support for farmers and ranchers globally.

Funding Details:

• Startup: Nofence

• Investors: European Circular Bioeconomy Fund (lead), Capagro, Nysnø Climate Investments, Climate Innovation Capital, Speedinvest; existing backers Sandwater, Momentum, Ferd.

• Amount Raised: Over $35 million

• Total Raised: Not disclosed

• Funding Stage: Series B

• Funding Date: September 16, 2025

Dualitas Therapeutics Raises $65M in Series A Funding for Immunology Drugs

Dualitas Therapeutics, a San Francisco biotech spun out in 2023, announced a $65 million Series A funding round co-led by Versant Ventures and Qiming Venture Partners USA, with pharmaceutical major Eli Lilly also participating. Dualitas is developing bispecific antibody therapies for immunity-related diseases, including two lead candidates targeting asthma and rheumatoid arthritis.

The company will use the funds to advance these candidates into clinical trials and to further develop its proprietary drug-discovery platform (DualScreen) for broader immunology applications.

Funding Details:

• Startup: Dualitas Therapeutics

• Investors: Versant Ventures (lead), Qiming Venture Partners USA (lead), Eli Lilly (participant), SV Health Investors, Chugai Venture Fund, Alexandria Venture Investments.

• Amount Raised: $65 million

• Total Raised: Not disclosed

• Funding Stage: Series A

• Funding Date: September 16, 2025

AllRock Bio Raises $50M in Series A Funding for Pulmonary Hypertension Drug

AllRock Bio, a Natick, Massachusetts clinical-stage biotech, has closed $50 million in Series A funding round. The financing was co-led by Versant Ventures and Westlake BioPartners. AllRock licensed its lead candidate (ROC-101), a first-in-class oral pan-ROCK inhibitor for pulmonary arterial hypertension, from Sanofi and will use the proceeds to advance this asset into Phase 2a clinical trials.

The funds will also support AllRock’s broader cardiopulmonary and fibrotic disease pipeline development. This Series A comes as AllRock prepares for upcoming trial readouts and builds a team experienced in rare disease drug development.

Funding Details:

• Startup: AllRock Bio

• Investors: Versant Ventures (co-lead), Westlake BioPartners (co-lead).

• Amount Raised: $50 million

• Total Raised: $50 million (all-time)

• Funding Stage: Series A

• Funding Date: September 16, 2025

WorkFusion Secures $45M Funding for AI-Powered Compliance

WorkFusion, a New York startup developing AI “agents” for financial-crime compliance, raised $45 million in funding. The round was led by Georgian Partners, which tripled down on its stake, and included participation from Serengeti Asset Management, NGP Capital, Teralys Capital, Hawk Equity, and other investors.

WorkFusion will use the investment to further develop its out-of-the-box AI agents (trained for tasks like sanctions screening, transaction monitoring, and fraud review) and to expand its commercial reach among major banks worldwide. The new capital brings WorkFusion’s total equity funding to about $251 million, positioning the company to grow its 25+ bank customers and scale its automated compliance platform.

Funding Details:

• Startup: WorkFusion

• Investors: Georgian Partners (lead), Serengeti Asset Management, NGP Capital, Teralys Capital, Hawk Equity, others.

• Amount Raised: $45 million

• Total Raised: $251 million (equity)

• Funding Stage: Late-stage / Series D (funding round)

• Funding Date: September 16, 2025

HALA Raises $157M in Series B Funding to Boost Fintech for SMEs

HALA, a Riyadh-based fintech platform for SME banking services, announced a $157 million Series B to boost fintech for small and midsize businesses. The round was co-led by TPG’s Rise Fund and Sanabil Investments (a PIF subsidiary), and included major regional and global investors such as QED Investors, Raed Ventures, Impact46, MEVP, Isometry Capital, Arzan VC, BNVT Capital, Kaltaire Investments, Endeavour Catalyst, Nour Nouf Ventures, Khwarizmi Ventures, and Wamda Capital.

HALA will use the fresh capital infusion to expand its embedded finance offerings in Saudi Arabia and the broader region, introduce lending products tailored to small businesses and freelancers, and further align with Saudi Arabia’s Vision 2030 SME-development goals. The funding underscores strong investor confidence in fintech-driven financial inclusion for the Middle East’s underserved SMEs.

Funding Details:

• Startup: HALA

• Investors: TPG’s Rise Fund (lead), Sanabil Investments (lead), QED Investors, Raed Ventures, Impact 46, MEVP, Isometry Capital, Arzan VC, BNVT Capital, Kaltaire Investments, Endeavour Catalyst, Nour Nouf Ventures, Khwarizmi Ventures, Wamda Capital.

• Amount Raised: $157 million

• Total Raised: Not disclosed

• Funding Stage: Series B

• Funding Date: September 16, 2025

Scalekit Secures $5.5M in Seed Funding to Accelerate AI Infrastructure

Bengaluru-based SaaS startup Scalekit has raised $5.5 million in a seed funding round. The round was led by Together Fund and Z47, with participation from angel investors Adam Frankl, Oliver Jay, and Jagadeesh Kunda. Scalekit builds modular “drop-in” infrastructure tools for SaaS and AI-first engineering teams.

The seed capital will be used to accelerate product development, expand its SaaS/AI infrastructure offerings, and scale the company’s operations globally.

Funding Details:

• Startup: Scalekit

• Investors: Together Fund (lead), Z47 (lead), Adam Frankl, Oliver Jay, Jagadeesh Kunda (angel investors).

• Amount Raised: $5.5 million

• Total Raised: $5.5 million (all-time)

• Funding Stage: Seed

• Funding Date: September 16, 2025

Vega Raises $65M in Series A Funding for Next-Gen Cybersecurity

Vega, an Israeli cybersecurity startup, has raised $65 million in early-stage funding, valuing the company at roughly $400 million. The round was led by Accel and included participation from Cyberstarts, Redpoint Ventures, and CRV.

Vega’s platform aims to reinvent security analytics for large enterprises; the startup plans to use the funding to expand R&D and U.S. operations (its primary market) as it commercializes its next-gen threat detection technology. Vega co-founder and CEO Shay Sandler noted that the company is already seeing strong traction with major U.S. retailers and financial institutions.

Funding Details:

• Startup: Vega

• Investors: Accel (lead), Cyberstarts, Redpoint Ventures, CRV.

• Amount Raised: $65 million

• Total Raised: $65 million (all-time)

• Funding Stage: Early-stage (Seed/Series A)

• Funding Date: September 16, 2025